DCLK1 was more frequently found in luminal cancers than basal-like and HER2-OE subtypes [15, 20, 21], associated with IBC-NED and potentially an independent favorable prognostic factor in these cancers. Here, DCLK1 is linked to inflammatory breast carcinoma.